Company intelligence / Profile preview

Sapala Organics

Hyderabad, Telangana, Indiasapalaorganics.com ↗

Ownership: Private
Development stage: Other

Overview

Sapala Organics specializes in advanced nucleic acid chemistry, offering custom synthesis of oligonucleotide building blocks and related compounds. The company supports pharmaceutical innovators from early R&D through commercial supply with expertise in complex amidite and nucleoside chemistries. It was acquired by Suven Pharmaceuticals in June 2024 to strengthen Suven’s position in high-growth oligonucleotide technologies.

Modalities: Small moleculeOligonucleotide (including modified nucleosides and phosphoramidites)Nucleic acid building blocks
Industry: Contract Manufacturing Organization

Partnerships

Suven Pharmaceuticals

Beyond the preview

Go deeper on Sapala Organics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sapala Organics.

Explore the full profile